Natriuretic peptide measurements for the diagnosis of "Nonsystolic" heart failure: Good news and bad

Journal of the American College of Cardiology

Volumn 41, Issue 11, 2003, Pages 2018-2021

  Massie, Barry M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ATHEROSCLEROSIS; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERTENSION; MEASUREMENT; MEDICAL ASSESSMENT; MYOCARDIAL DISEASE; NON SYSTOLIC HEART FAILURE; NOTE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; SYSTOLE; VASCULAR DISEASE;

EID: 0037638734     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00395-4     Document Type: Editorial

References (20)

1. Maisel AS, McCord J, Nowak RM, et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly (BNP) multinational study. J Am Coll Cardiol 2003;41:2010-7.
2. Maisel AS, Krisnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
3. Dauterman KW, Massie BM, Gheorghiade M. Heart failure with preserved systolic function: a common and costly clinical entity. Am Heart J 1998;135 Suppl:S310-19.
4. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, MN, in 1991. Circulation 1998;98:2282-9.
5. Vasan RS, Larson MG, Benjamin FJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
6. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥65 years of age. Cardiovascular Health Study. Am J Cardiol 2001;87:413-9.
7. Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002;8:279-87.
8. Zile MR, Gaasch WH, Carroll JD, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001;104:779-82.
9. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of the left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. J Am Coll Cardiol 1997;30:8-18.
10. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Bailey KR. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 1994;69:212-4.
11. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in the assessment of patients with possible new heart failure in primary care. Lancet 1997;350:2347-51.
12. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998;351:9-13.
13. Maeda K, Takayoshi T, Wada A, Hisangaga T, Knoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
14. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601.
15. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in the emergency diagnosis of heart failure. Circulation 2002;106:416-22.
16. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age. J Am Coll Cardiol 2002;40:976-82.
17. Masoudi FA, Havranek EP, Smith G, et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003;41:217-23.
18. Sayama H, Nakamura Y, Saito N, Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis 1999;10:537-40.
19. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaption to isolated systolic hypertension. Am J Cardiol 1993;72:310-3.
20. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-37.